Replication licensing and cancer--a fatal entanglement? - PubMed (original) (raw)
Review
. 2008 Oct;8(10):799-806.
doi: 10.1038/nrc2500. Epub 2008 Aug 29.
Affiliations
- PMID: 18756287
- PMCID: PMC2577763
- DOI: 10.1038/nrc2500
Review
Replication licensing and cancer--a fatal entanglement?
J Julian Blow et al. Nat Rev Cancer. 2008 Oct.
Abstract
Correct regulation of the replication licensing system ensures that chromosomal DNA is precisely duplicated in each cell division cycle. Licensing proteins are inappropriately expressed at an early stage of tumorigenesis in a wide variety of cancers. Here we discuss evidence that misregulation of replication licensing is a consequence of oncogene-induced cell proliferation. This misregulation can cause either under- or over-replication of chromosomal DNA, and could explain the genetic instability commonly seen in cancer cells.
Figures
Figure 1
Overview of origin licensing during the cell division cycle. A small segment of chromosomal DNA, encompassing 3 replication origins is shown during the cell cycle. Mcm2-7 complexes (here shown as a double hexamer) are loaded onto origins during G1 when the licensing system is active (green). During S phase, Mcm2-7 complexes at licensed origins are activated to from part of the replication fork. When replication forks terminate, Mcm2-7 is displaced from the DNA. Prior to entry into S phase, the licensing system is shut down (pink shading) so Mcm2-7 cannot be loaded onto unreplicated DNA. This occurs as a consequence of geminin activation and Cdt1 degradation during S and G2, plus high CDK activity during mitosis. On exit from the cell cycle into G0, terminal differentiation or senescence, the licensing system is inactivated and Mcm2-7 are degraded.
Figure 2
Mcm5 in normal and dysplastic cervical epithelium. Frozen sections of normal cervix (a), low-grade (b) and high-grade (c) squamous intraepithelial lesions stained with antibodies against Mcm5. Magnification x108. Reproduced from .
Figure 3
The DNA damage response. Cartoon summarising major components of the DNA damage response (DDR) system that are active during S phase. Defects occurring at the DNA are sensed, and through the activation of the signal transducers leads to cellular responses.
Figure 4
Consequences of re-replication A small segment of chromosomal DNA containing a replication origin is shown. (a) A single re-initiation event generates a bubble of re-replicated DNA. If the rate of re-initiation is high, forks be initiated sufficiently close together that they undergo head-to-tail collision (b-c). The resultant bubble structures (d) may undergo recombination to form either extrachromosomal circles (e) or tandem chromosomal duplications (f). (Lines in (a-c) indicate single DNA strands, lines in (d-f) indicate double DNA strands.
Figure 5
Dormant origins and replication fork stalling. A small section of chromosomal DNA replicated by 2-3 origins is shown. Mcm2-7 double hexamers are shown as a pink oval. (a) If two converging forks stall with no dormant origin between them, the result is likely to be DNA breakage or rescue by recombination. (b) In the absence of fork stalling, the dormant origin between the two active origins does not initiate, and its Mcm2-7 proteins are passively displaced as they are replicated. (c) If the converging forks stall, the dormant origin between them can initiate and allow complete replication of the chromosomal segment.
Similar articles
- Prospect of reprogramming replication licensing for cancer drug development.
Kyei Barffour I, Acheampong DO. Kyei Barffour I, et al. Biomed Pharmacother. 2021 Apr;136:111190. doi: 10.1016/j.biopha.2020.111190. Epub 2021 Jan 23. Biomed Pharmacother. 2021. PMID: 33497909 Review. - The role of the replication licensing system in cell proliferation and cancer.
Shreeram S, Blow JJ. Shreeram S, et al. Prog Cell Cycle Res. 2003;5:287-93. Prog Cell Cycle Res. 2003. PMID: 14593723 Free PMC article. Review. - The MCM complex: its role in DNA replication and implications for cancer therapy.
Lei M. Lei M. Curr Cancer Drug Targets. 2005 Aug;5(5):365-80. doi: 10.2174/1568009054629654. Curr Cancer Drug Targets. 2005. PMID: 16101384 Review. - The Licensing Factor Cdt1 Links Cell Cycle Progression to the DNA Damage Response.
Kanellou A, Giakoumakis NN, Panagopoulos A, Tsaniras SC, Lygerou Z. Kanellou A, et al. Anticancer Res. 2020 May;40(5):2449-2456. doi: 10.21873/anticanres.14214. Anticancer Res. 2020. PMID: 32366388 Review. - Replication licensing promotes cyclin D1 expression and G1 progression in untransformed human cells.
Liu P, Slater DM, Lenburg M, Nevis K, Cook JG, Vaziri C. Liu P, et al. Cell Cycle. 2009 Jan 1;8(1):125-36. doi: 10.4161/cc.8.1.7528. Epub 2009 Jan 1. Cell Cycle. 2009. PMID: 19106611 Free PMC article.
Cited by
- Role of Geminin as a Tool for Augmenting Accurate Diagnosis of Cervical Neoplasia.
Bagde ND, Bagde MN, Agrawal S, Nayak P, Negi SS, Rajbhar S, Hussain N. Bagde ND, et al. Cureus. 2024 Mar 25;16(3):e56864. doi: 10.7759/cureus.56864. eCollection 2024 Mar. Cureus. 2024. PMID: 38659554 Free PMC article. - Quantity and quality of minichromosome maintenance protein complexes couple replication licensing to genome integrity.
Yadav AK, Polasek-Sedlackova H. Yadav AK, et al. Commun Biol. 2024 Feb 9;7(1):167. doi: 10.1038/s42003-024-05855-w. Commun Biol. 2024. PMID: 38336851 Free PMC article. Review. - Genome maintenance meets mechanobiology.
Spegg V, Altmeyer M. Spegg V, et al. Chromosoma. 2024 Jan;133(1):15-36. doi: 10.1007/s00412-023-00807-5. Epub 2023 Aug 15. Chromosoma. 2024. PMID: 37581649 Free PMC article. Review. - Interplay between chromosomal architecture and termination of DNA replication in bacteria.
Goodall DJ, Warecka D, Hawkins M, Rudolph CJ. Goodall DJ, et al. Front Microbiol. 2023 Jun 26;14:1180848. doi: 10.3389/fmicb.2023.1180848. eCollection 2023. Front Microbiol. 2023. PMID: 37434703 Free PMC article. Review. - Small and Large Extracellular Vesicles Derived from Pleural Mesothelioma Cell Lines Offer Biomarker Potential.
Ahmadzada T, Vijayan A, Vafaee F, Azimi A, Reid G, Clarke S, Kao S, Grau GE, Hosseini-Beheshti E. Ahmadzada T, et al. Cancers (Basel). 2023 Apr 18;15(8):2364. doi: 10.3390/cancers15082364. Cancers (Basel). 2023. PMID: 37190292 Free PMC article.
References
- Nishitani H, Lygerou Z. DNA replication licensing. Frontiers in Bioscience. 2004;9:2115–2132. - PubMed
- Arias EE, Walter JC. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Genes Dev. 2007;21:497–518. - PubMed
- Labib K, Diffley JF. Is the MCM2-7 complex the eukaryotic DNA replication fork helicase? Curr Opin Genet Dev. 2001;11:64–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- A5434/CRUK_/Cancer Research UK/United Kingdom
- A7399/CRUK_/Cancer Research UK/United Kingdom
- C303/A7399/CRUK_/Cancer Research UK/United Kingdom
- C303/A5434/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources